Key Highlights

• Rock Tech was highly active through 2026.
• In July, it secured a binding long-term spodumene offtake agreement with Transamine, together with a development prepayment Facility of up to about US$80 million, advancing its integrated Ontario mine-to-converter strategy.
• The 2026 milestones — the Transamine offtake and prepayment facility, the BMI Group anchor partnership, the Siemens technology transfer and the various financings — show the company advancing its vision and attracting partners and strategic market watchers.
• However, the Capital required to build a converter and develop mines is enormous relative to the roughly CA$6.6 million in 2026 Equity raises, so…